387 related articles for article (PubMed ID: 32623455)
21. HIV prevention and HIV care among transgender and gender diverse youth: design and implementation of a multisite mixed-methods study protocol in the U.S.
Jadwin-Cakmak L; Reisner SL; Hughto JMW; Salomon L; Martinez M; Popoff E; Rivera BA; Harper GW
BMC Public Health; 2019 Nov; 19(1):1531. PubMed ID: 31730450
[TBL] [Abstract][Full Text] [Related]
22. Assessing Eligibility for Lung Cancer Screening Among Women Undergoing Screening Mammography: Cross-Sectional Survey Results From the National Health Interview Survey.
López DB; Flores EJ; Miles RC; Wang GX; Glover M; Shepard JO; Lehman CD; Narayan AK
J Am Coll Radiol; 2019 Oct; 16(10):1433-1439. PubMed ID: 31092347
[TBL] [Abstract][Full Text] [Related]
23. Gambling Behaviors and Problem Gambling: A Population-Based Comparison of Transgender/Gender Diverse and Cisgender Adolescents.
Rider GN; McMorris BJ; Gower AL; Coleman E; Eisenberg ME
J Gambl Stud; 2019 Mar; 35(1):79-92. PubMed ID: 30343416
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of cancer risk factors among transgender and gender diverse individuals: a cross-sectional analysis using UK primary care data.
Brown J; Pfeiffer RM; Shrewsbury D; O'Callaghan S; Berner AM; Gadalla SM; Shiels MS; Jackson SS
Br J Gen Pract; 2023 Jul; 73(732):e486-e492. PubMed ID: 37365010
[TBL] [Abstract][Full Text] [Related]
25. Gender Identity Disparities in Cancer Screening Behaviors.
Tabaac AR; Sutter ME; Wall CSJ; Baker KE
Am J Prev Med; 2018 Mar; 54(3):385-393. PubMed ID: 29338956
[TBL] [Abstract][Full Text] [Related]
26. Breast and cervical cancer screenings across gender identity: results from the Behavioral Risk Factor Surveillance System before and during the COVID-19 pandemic.
Berzansky I; Reynolds CA; Charlton BM
Cancer Causes Control; 2024 May; 35(5):865-872. PubMed ID: 38280155
[TBL] [Abstract][Full Text] [Related]
27. Lung cancer screening provider recommendation and completion in black and White patients with a smoking history in two healthcare systems: a survey study.
Japuntich SJ; Walaska K; Friedman EY; Balletto B; Cameron S; Tanzer JR; Fang P; Clark MA; Carey MP; Fava J; Busch AM; Breault C; Rosen R
BMC Prim Care; 2024 Jun; 25(1):202. PubMed ID: 38849725
[TBL] [Abstract][Full Text] [Related]
28. Cigarette, smokeless tobacco, and alcohol use among transgender adults in the United States.
Azagba S; Latham K; Shan L
Int J Drug Policy; 2019 Nov; 73():163-169. PubMed ID: 31353246
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with low-dose CT lung cancer screening participation in a high burden state: Results from the 2017-2018 BRFSS.
Sedani AE; Ford LA; James SA; Beebe LA
J Cancer Policy; 2021 Jun; 28():100284. PubMed ID: 35559913
[TBL] [Abstract][Full Text] [Related]
30. Lung Cancer Screening Eligibility and Use: A Population Health Perspective of One Community.
Tailor TD; Farrow NE; Gao J; Choudhury KR; Tong BC
N C Med J; 2021; 82(5):321-326. PubMed ID: 34544766
[No Abstract] [Full Text] [Related]
31. Social Stressors and Health Among Older Transgender and Gender Diverse Veterans.
Jasuja GK; Reisman JI; Rao SR; Wolfe HL; Hughto JMW; Reisner SL; Shipherd JC
LGBT Health; 2023; 10(2):148-157. PubMed ID: 36454239
[No Abstract] [Full Text] [Related]
32. Improving Utilization of Lung Cancer Screening Through Incorporating a Video-Based Educational Tool Into Smoking Cessation Counseling.
Raz DJ; Ismail MH; Haupt EC; Sun V; Park S; Alem AC; Gould MK
Clin Lung Cancer; 2021 Mar; 22(2):83-91. PubMed ID: 33436279
[TBL] [Abstract][Full Text] [Related]
33. Patient-Provider Lung Cancer Screening Discussions: An Analysis of a National Survey.
Nourmohammadi N; Liang THP; Sadigh G
Clin Lung Cancer; 2024 Jun; 25(4):e189-e195.e2. PubMed ID: 38522980
[TBL] [Abstract][Full Text] [Related]
34. LDCT lung cancer screening eligibility and use of CT scans for lung cancer among sexual minorities.
Veliz P; Matthews AK; Arslanian-Engoren C; Evans-Polce RJ; Lee JGL; Boyd CJ; Hughes T; McCabe VV; McCabe SE
Cancer Epidemiol; 2019 Jun; 60():51-54. PubMed ID: 30909153
[TBL] [Abstract][Full Text] [Related]
35. Prostate Cancer Screening Uptake in Transgender Women.
Kalavacherla S; Riviere P; Kalavacherla S; Anger JT; Murphy JD; Rose BS
JAMA Netw Open; 2024 Feb; 7(2):e2356088. PubMed ID: 38353948
[TBL] [Abstract][Full Text] [Related]
36. Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement.
Rivera MP; Katki HA; Tanner NT; Triplette M; Sakoda LC; Wiener RS; Cardarelli R; Carter-Harris L; Crothers K; Fathi JT; Ford ME; Smith R; Winn RA; Wisnivesky JP; Henderson LM; Aldrich MC
Am J Respir Crit Care Med; 2020 Oct; 202(7):e95-e112. PubMed ID: 33000953
[No Abstract] [Full Text] [Related]
37. Psychiatric Diagnoses Among Transgender and Gender Diverse Patients Compared to Cisgender Patients.
Zimmerman M; Benjamin I; Seijas-Rodriguez C
J Clin Psychiatry; 2022 Sep; 83(6):. PubMed ID: 36170202
[No Abstract] [Full Text] [Related]
38. Non-suicidal self-injury, suicide ideation, and past suicide attempts: Comparison between transgender and gender diverse veterans and non-veterans.
Aboussouan A; Snow A; Cerel J; Tucker RP
J Affect Disord; 2019 Dec; 259():186-194. PubMed ID: 31446379
[TBL] [Abstract][Full Text] [Related]
39. Review of Breast Imaging in Transgender and Gender-Diverse Patients: Gender-Affirming Care, Histopathologic Findings, Breast Cancer Risk, and Screening Recommendations.
Chowdhury A; Saad Eddin A; Kim Hsieh S; Policeni FC
J Breast Imaging; 2024 May; 6(3):238-245. PubMed ID: 38613363
[TBL] [Abstract][Full Text] [Related]
40. Screening for lung cancer: 2023 guideline update from the American Cancer Society.
Wolf AMD; Oeffinger KC; Shih TY; Walter LC; Church TR; Fontham ETH; Elkin EB; Etzioni RD; Guerra CE; Perkins RB; Kondo KK; Kratzer TB; Manassaram-Baptiste D; Dahut WL; Smith RA
CA Cancer J Clin; 2024; 74(1):50-81. PubMed ID: 37909877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
